Nuvation bio to present at the 7th annual evercore isi healthconx conference

New york--(business wire)--nuvation bio inc. (nyse: nuvb), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that david hung, m.d., founder, president, and chief executive officer of nuvation bio, will participate in a fireside chat at the 7th annual evercore isi healthconx conference in coral gables, florida, on wednesday, december 4, 2024, at 9:10 a.m. et. a live webcast of the fireside chat will be available on the.
EVR Ratings Summary
EVR Quant Ranking